Territorial Availability: Available through Bertin Technologies only in France
Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.
Special Advice: Please check regulation status before ordering; additionel fees can apply.
- Synonyms
- 4-?(2-?aminopropyl)?-phenol, monohydrochloride
- Correlated keywords
- 1518-86-1 103-86-6 6078-?07-?5 51345-?30-?3 hydroxyamfetamine INN Paredrine Mycadrine Pedrolon hydroxyamphetamines oxamphetamine norpholedrine para-hydroxyamphetamine POHA ?-methyltyramine metabolites plants alkaloids nights vision Horner’s syndromes sympathomimetic trace amine-associated receptors 1 TAAR1 hydroxy TAAR-1 TAAR 1 one TAAR amphetamines HCl 4 four analytical references standards HA 4-HA bioactive amphetamines agonists amines associated HEK-293 HEK293 HEK 293 cells rats ophthalmologic solutions dilates pupils diagnosis Horners forensics research purpores ? methyltyramines alpha- methyltyramines .alpha.- methyltyramines alpha .alpha. para
- Product Overview:
4-Hydroxyamphetamine (4-HA) is a bioactive metabolite of amphetamine.{24225,24227} This sympathomimetic is an agonist of the trace amine-associated receptor 1 (EC50 = ~0.2 ?M in HEK293 cells expressing rat TAAR1).{24228} As a 1% ophthalmologic solution, 4-HA has been used to dilate the pupil in the diagnosis of Horner’s syndrome.{24224,24226} This product is intended only for forensic and research purposes.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.